Santhosh Reddy Meedimale, Consultant Medical Oncologist at Omega Hospitals, shared a post on LinkedIn:
“I’m delighted to share that our case series on Biosimilar Nivolumab has been published.
This represents the first published case series from India evaluating the real-world use of Biosimilar Nivolumab, adding valuable evidence to the growing body of literature on immunotherapy in oncology.
It is a matter of immense pride to have contributed to this work from Omega Hospitals Karimnagar, demonstrating that meaningful clinical research and scientific contributions can emerge from centers beyond major metropolitan institutions.
I am grateful to all my co-authors, mentors, colleagues, and patients who made this work possible. I hope this publication encourages more real-world research and collaborative academic efforts across India.”
Title: Biosimilar Nivolumab-Based Combination Therapy in Advanced Oral Cavity Squamous Cell Carcinoma: A Real-World Case Series of Five Patients
Authors: Santhosh Meedimale, Soumya S. Panda, Vipulkumar Thummar, Harsh Bhavsar
Read The Full Article
